These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34288258)

  • 1. Platelet-rich plasma and cytokines in neuropathic pain: A narrative review and a clinical perspective.
    Bohren Y; Timbolschi DI; Muller A; Barrot M; Yalcin I; Salvat E
    Eur J Pain; 2022 Jan; 26(1):43-60. PubMed ID: 34288258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors.
    Amable PR; Carias RB; Teixeira MV; da Cruz Pacheco I; Corrêa do Amaral RJ; Granjeiro JM; Borojevic R
    Stem Cell Res Ther; 2013 Jun; 4(3):67. PubMed ID: 23759113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cytokines for treatment of neuropathic pain.
    Hung AL; Lim M; Doshi TL
    Scand J Pain; 2017 Oct; 17():287-293. PubMed ID: 29229214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synovial fluid growth factor and cytokine concentrations after intra-articular injection of a platelet-rich product in horses.
    Textor JA; Willits NH; Tablin F
    Vet J; 2013 Oct; 198(1):217-23. PubMed ID: 23992870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow concentrate and platelet-rich plasma differ in cell distribution and interleukin 1 receptor antagonist protein concentration.
    Cassano JM; Kennedy JG; Ross KA; Fraser EJ; Goodale MB; Fortier LA
    Knee Surg Sports Traumatol Arthrosc; 2018 Jan; 26(1):333-342. PubMed ID: 26831858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Platelet-Rich Plasma Treatment for Spinal Diseases: A Systematic Review.
    Kawabata S; Akeda K; Yamada J; Takegami N; Fujiwara T; Fujita N; Sudo A
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma.
    Sundman EA; Cole BJ; Fortier LA
    Am J Sports Med; 2011 Oct; 39(10):2135-40. PubMed ID: 21846925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidation of pathophysiology and treatment of neuropathic pain.
    Vranken JH
    Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):304-14. PubMed ID: 23033930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous growth factor injections in chronic tendinopathy.
    Sandrey MA
    J Athl Train; 2014; 49(3):428-30. PubMed ID: 24840581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Growth Factors, Cytokines, and Chemokines in Bone Marrow Concentrate and Platelet-Rich Plasma: A Prospective Analysis.
    Ziegler CG; Van Sloun R; Gonzalez S; Whitney KE; DePhillipo NN; Kennedy MI; Dornan GJ; Evans TA; Huard J; LaPrade RF
    Am J Sports Med; 2019 Jul; 47(9):2174-2187. PubMed ID: 31034242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties.
    El-Sharkawy H; Kantarci A; Deady J; Hasturk H; Liu H; Alshahat M; Van Dyke TE
    J Periodontol; 2007 Apr; 78(4):661-9. PubMed ID: 17397313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte-Rich Platelet-Rich Plasma as an Effective Source of Molecules That Modulate Local Immune and Inflammatory Cell Responses.
    Dejnek M; Moreira H; Płaczkowska S; Barg E; Reichert P; Królikowska A
    Oxid Med Cell Longev; 2022; 2022():8059622. PubMed ID: 35958021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines.
    Austin PJ; Moalem-Taylor G
    J Neuroimmunol; 2010 Dec; 229(1-2):26-50. PubMed ID: 20870295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticytokine therapy in neuropathic pain management.
    Schäfers M; Sommer C
    Expert Rev Neurother; 2007 Nov; 7(11):1613-27. PubMed ID: 17997707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine Profiling and Intra-Articular Injection of Autologous Platelet-Rich Plasma in Knee Osteoarthritis.
    Riewruja K; Phakham S; Sompolpong P; Reantragoon R; Tanavalee A; Ngarmukos S; Udomsinprasert W; Suantawee T; Dechsupa S; Honsawek S
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-Rich Plasma Injection in Burn Scar Areas Alleviates Neuropathic Scar Pain.
    Huang SH; Wu SH; Lee SS; Lin YN; Chai CY; Lai CS; Wang HD
    Int J Med Sci; 2018; 15(3):238-247. PubMed ID: 29483815
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelet-rich plasma and the elimination of neuropathic pain.
    Kuffler DP
    Mol Neurobiol; 2013 Oct; 48(2):315-32. PubMed ID: 23832571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of glial activation in neuropathic pain.
    Mika J; Zychowska M; Popiolek-Barczyk K; Rojewska E; Przewlocka B
    Eur J Pharmacol; 2013 Sep; 716(1-3):106-19. PubMed ID: 23500198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of glia and the immune system in the development and maintenance of neuropathic pain.
    Vallejo R; Tilley DM; Vogel L; Benyamin R
    Pain Pract; 2010; 10(3):167-84. PubMed ID: 20384965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of cytokine levels and clinical effect on platelet-rich plasma-treated lateral epicondylitis.
    Lim W; Park SH; Kim B; Kang SW; Lee JW; Moon YL
    J Orthop Res; 2018 Mar; 36(3):913-920. PubMed ID: 28851099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.